(19)
(11) EP 1 345 891 A1

(12)

(43) Date of publication:
24.09.2003 Bulletin 2003/39

(21) Application number: 01996529.2

(22) Date of filing: 15.11.2001
(51) International Patent Classification (IPC)7C07C 275/28, C07C 275/34, C07C 275/32, C07C 275/40, C07D 319/08, C07D 319/20, C07D 209/48, C07D 271/06, C07D 333/36, C07D 257/04, A61K 31/197, A61K 31/41, A61P 3/10, A61P 3/04
(86) International application number:
PCT/DK0100/760
(87) International publication number:
WO 0204/0446 (23.05.2002 Gazette 2002/21)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.11.2000 DK 200001733

(71) Applicant: Novo Nordisk A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • JORGENSEN, Anker, Steen
    DK-2100 Copenhagen (DK)
  • MADSEN, Peter
    DK-2880 Bagsvaerd (DK)

   


(54) GLUCAGON ANTAGONIST/INVERSE AGONIST